Ongoing Device Developments to Assess Brain Injuries to Promote Global Market

Published: Mar 2024

The global traumatic brain injury assessment & management device market is anticipated to grow at a considerable CAGR of 7.2% during the forecast period (2024-2031). The ongoing development in traumatic brain injury assessment & management device along with growing number of the FDA approval is a key factor driving the global market gro9wth. For instance, in March 2023, Abbott has received FDA clearance for the first commercially available laboratory-based blood test designed to help assess concussion. The test will be run on Abbott's Alinityi laboratory instrument, and will be widely available to hospitals in the United States. The blood test provides clinicians with an objective way to quickly evaluate individuals with mild traumatic brain injury (TBI), commonly known as concussions.

Browse the full report description of “Traumatic Brain Injury Assessment & Management Devices Market Size, Share & Trends Analysis Report by Device (Imaging Device andMonitoring Device), and by End-User (Hospitals, Diagnostic Center, and Others) Forecast Period (2024-2031)” at https://www.omrglobal.com/industry-reports/traumatic-brain-injury-assessment-and-management-devices-market

Additionally, in February 2021, the US FDA has authorized the marketing of a new device called the Q-Collar, which is intended for athletes aged 13 years and older. The non-invasive device is worn around the neck during sports activities to help protect the brain from the repetitive sub-concussive impacts associated with sports. The C-shaped collar applies compressive force to the neck, increasing blood volume and reducing the movement of the brain within the cranial space during head impacts. This may reduce the occurrence of specific changes in the brain associated with injury.

Market Coverage

Base year- 2023

Forecast period- 2024-2031

Segment Covered- 

o By Device

o By End-User

Regions Covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

Competitive Landscape-  Integra LifeSciences Corp., Nihon Kohden Corp., Abbott Laboratories,  Boston Scientific Corp., and Koninklijke Philips N.V. among others.

Key questions addressed by the report.

  • What is the market growth rate?
  • Which segment and region dominate the market in the base year?
  • Which segment and region will project the fastest growth in the market?
  • Who is the leader in the market?
  • How are players addressing challenges to sustain growth?
  • Where is the investment opportunity?

Global traumatic Brain Injury Assessment & Management Device Market Report Segment

By Device

  • Imaging Device
  • Monitoring Device

By End-User

  • Hospitals
  • Diagnostic Centers
  • Other (Ambulatory Surgical Center)

Global Traumatic Brain Injury Assessment & Management Device Market Report Segment by Region

North America

United States

Canada

Europe

UK

Germany

Italy

Spain

France

Rest of Europe 

Asia-Pacific

China

India

Japan

South Korea

Rest of Asia-Pacific 

Rest of the World

Latin America 

Middle East & Africa


To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/traumatic-brain-injury-assessment-and-management-devices-market